About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Wdfy3Tn(pb-Act-RFP)1.1Zhu
transposon insertion 1.1, Yuan Zhuang
MGI:6433103
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Wdfy3Tn(pb-Act-RFP)1.1Zhu/Wdfy3Tn(pb-Act-RFP)1.1Zhu involves: C57BL/6 * FVB/NJ MGI:6433751


Genotype
MGI:6433751
hm1
Allelic
Composition
Wdfy3Tn(pb-Act-RFP)1.1Zhu/Wdfy3Tn(pb-Act-RFP)1.1Zhu
Genetic
Background
involves: C57BL/6 * FVB/NJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Wdfy3Tn(pb-Act-RFP)1.1Zhu mutation (0 available); any Wdfy3 mutation (210 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• only 10.8% of homozygous embryos are recovered neonatally but all newborns die within several hours after birth
• homozygous embryos are present at Mendelian ratios at E10.5 (22.1%); however, the survival rate drops at E12.5 (20% vs expected 25%), E14.5 (14.9%) and E18.5 (14.6%)

homeostasis/metabolism
• newborns appear grossly pale or cyanotic
• at E14.5, a subset of embryos display peripheral edema

integument
• newborns appear grossly pale or cyanotic

growth/size/body
• newborns are significantly smaller than wild-type controls
• at E18.5, body weight of embryos delivered by Cesarean section is significantly lower than that in wild-type controls

cardiovascular system
• at E14.5, embryos exhibit various congenital heart defects
• transgenic overexpression of a C-terminal fragment of Wdfy3 fails to rescue the cardiac defects
• at E14.5, all (17 o 17) embryos exhibit disorganized ventricular trabeculation in both left ventricle (LV) and right ventricle (RV)
• disorganized trabeculation is also observed at E12.5, E13.5 and E15.5
• at E14.5, mRNA levels of Nkx2-5 (NK2 homeobox 5) and Mef2c (myocyte enhancer factor 2C), two cardiac core transcription factors required for heart formation and development, are significantly decreased in the heart
• at E12.5 and E14.5, cell proliferation is significantly reduced in the myocardium of the LV, RV, and interventricular septum, as determined by the % of BrdU+ cells
• at E14.5, decreased cell proliferation is associated with increased cardiac Cdkn1a (cyclin dependent kinase inhibitor 1A) mRNA and protein levels
• Notch1 signaling is perturbed leading to reduced protein levels of Notch1 intracellular domain (N1ICD) and its downstream targets Hes1 and Hey1, and enhanced full-length (uncleaved) Notch1 protein levels
• no differences in apoptotic cell death are noted in the heart at E12.5 or E14.5
• no change in LC3 II and p62 protein abundance or in ubiquitinated protein levels is noted in the heart at E14.5, indicating normal autophagy
• at E14.5, mRNA levels of two cardiomyocyte specific markers, Myh6 (myosin, heavy polypeptide 6, cardiac muscle, alpha) and Myl2 (myosin, light polypeptide 2, regulatory, cardiac, slow; aka MLC2v), are significantly reduced in the heart, suggesting diminished cardiomyocyte differentiation
• at E14.5, five of 17 (29.4%) embryos display a VSD combined with DORV
• at E14.5, six of 17 embryos (35.3%) display a large VSD combined with an overriding aorta
• at E14.5, all (17 o 17) embryos exhibit a membranous ventricular septal defect (VSD)
• among these 17 embryos, six (35.3%) show a VSD without an outflow tract (OFT) defect, another six (35.3%) display a large VSD with an overriding aorta, and five (29.4%) display a VSD with double outlet right ventricle (DORV)
• VSD is also observed at E15.5
• at E14.5, all (17 o 17) embryos exhibit a thinned ventricular wall
• thinning of the ventricular wall is also observed at E12.5, E13.5 and E15.5
• at E14.5, all (17 o 17) embryos exhibit ventricular dilation
• ventricular dilation is also observed at E12.5, E13.5 and E15.5

muscle
• at E14.5, all (17 o 17) embryos exhibit disorganized ventricular trabeculation in both left ventricle (LV) and right ventricle (RV)
• disorganized trabeculation is also observed at E12.5, E13.5 and E15.5

cellular
N
• after vehicle or bafilomycin A1 treatment, primary MEFs isolated from E12.5 embryos show no differences in LC3 II and p62 protein abundance relative to similarly treated wild-type MEFs, indicating a normal autophagic flux
• no change in general autophagy and selective degradation of protein aggregates is noted in the heart at E14.5





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory